The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation

被引:74
作者
Maasho, K [1 ]
Masilamani, M [1 ]
Valas, R [1 ]
Basu, S [1 ]
Coligan, JE [1 ]
Borrego, F [1 ]
机构
[1] NIAID, Receptor Cell Biol Sect, Lab Allerg Dis, NIH, Rockville, MD 20852 USA
关键词
LAIR-1; naive T cell; inhibitory receptor; CD8;
D O I
10.1016/j.molimm.2005.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human leukocyte-associated Ig-like receptor-1 (LAIR-1) is a transmembrane glycoprotein with a single extracellular Ig-like domain and a cytoplasmic tail containing two immunoreceptor tyrosine-based inhibition motifs (ITIMs). It is constitutively expressed on the majority of human mononuclear leukocytes and functions as an inhibitory receptor. In this study, we show that freshly isolated peripheral blood T cells are heterogeneous in their expression levels of LAIR. We have found that naive T cells express the highest levels of LAIR-1, even more than memory cells. The cross-linking of LAIR-1 inhibits T cell receptor (TCR) mediated signals in freshly isolated human naive T cells and whole populations of CD4(+) or CD8(+) T cells. TCR cross-linking increased cell surface expression of LAIR-1 in a process that requires p38 MAP kinase and ERK signaling. Altogether, these results indicate that LAIR-1 is capable of negatively regulating T cell functions, and its high level of expression by naive T cells suggests that it may function at an early stage in the development of an immune response. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1521 / 1530
页数:10
相关论文
共 48 条
[1]   Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor [J].
Acuto, O ;
Mise-Omata, S ;
Mangino, G ;
Michel, F .
IMMUNOLOGICAL REVIEWS, 2003, 192 (01) :21-31
[2]   Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells [J].
Aoukaty, A ;
Lee, IF ;
Wu, J ;
Tan, RS .
JOURNAL OF CLINICAL IMMUNOLOGY, 2003, 23 (02) :141-145
[3]   Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells [J].
Borrego, F ;
Kabat, J ;
Kim, DK ;
Lieto, L ;
Maasho, K ;
Peña, J ;
Solana, R ;
Coligan, JE .
MOLECULAR IMMUNOLOGY, 2002, 38 (09) :637-660
[4]   BTLA: a new inhibitory receptor with a B7-like ligand [J].
Carreno, BM ;
Collins, M .
TRENDS IN IMMUNOLOGY, 2003, 24 (10) :524-527
[5]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53
[6]   Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 receptor in Jurkat T cells [J].
Chwae, YJ ;
Chang, MJ ;
Park, SM ;
Yoon, H ;
Park, HJ ;
Kim, SJ ;
Kim, J .
JOURNAL OF IMMUNOLOGY, 2002, 169 (07) :3726-3735
[7]   Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection [J].
De Milito, A ;
Nilsson, A ;
Titanji, K ;
Thorstensson, R ;
Reizenstein, E ;
Narita, M ;
Grutzmeier, S ;
Sönnerborg, A ;
Chiodi, F .
BLOOD, 2004, 103 (06) :2180-2186
[8]  
de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160
[9]   CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[10]   Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts [J].
Goldrath, AW ;
Bevan, MJ .
IMMUNITY, 1999, 11 (02) :183-190